Midwestern Regional Medical Center; Office of Research

Zion, Illinois 60099

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Non-Small-Cell Lung Carcinoma

Studies at this site

• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed
• A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed